Clinical trials recruiting for Recurrent Breast Cancer
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Alabama | 1 |
| Arizona | 1 |
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| Florida | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Massachusetts | 1 |
| Minnesota | 1 |
| Missouri | 1 |
| Nevada | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.
- A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
- Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer
Related conditions
Trials recruiting for Recurrent Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Recurrent Breast Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.